...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-epsilon 4 Carriers
【24h】

The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-epsilon 4 Carriers

机译:UCP4的遗传变异影响个体对迟发性阿尔茨海默氏病的易感性,并改变该疾病在APOE-ε4携带者中的风险

获取原文
获取原文并翻译 | 示例
           

摘要

Uncoupling proteins (UCPs) are a group of five mitochondrial inner membrane transporters with a tissue specific expression that uncouple biofuel oxidation from ATP synthesis and function as regulators of energy homeostasis and antioxidants. Previous data suggested that neuronal UCPs (UCP2, UCP4, and UCP5) can directly influence synaptic plasticity, neurotransmission, and neurodegenerative processes, and have a crucial role in the function and protection of the central nervous system. In fact, it has been observed that the expression of neuronal UCPs significantly decreases in Alzheimer's disease (AD) patients. Here we analyzed the variability of UCP2, -3, -4, and 5 genes in sporadic and familial cases (n = 465) of late-onset AD (LOAD) with respect to healthy controls (n = 442). We showed that a genetic variant in the human UCP4, rs9472817, not only significantly affects the individual susceptibility to LOAD, but also modulates the effect of APOE-epsilon 4 on AD risk. In fact, rs9472817-C allele was significantly more frequent in both groups of patients with respect to the control group (p = 6.934*10(-4) for familial and p = 1.033* 10(-3) for sporadic cases). In addition, gene-gene interaction analysis revealed that the effect of APOE-epsilon 4 allele on LOAD risk was doubled in homozygote CC subjects; conversely, the risk conferred by the APOE-epsilon 4 allele was annulled in subjects with two copies of the G allele. Our findings are further evidence that the efficiency in mitochondrial energy metabolism and oxidative stress are important factors in AD pathogenesis.
机译:解偶联蛋白(UCP)是一组五个线粒体内膜转运蛋白,具有组织特异性表达,可将生物燃料氧化与ATP合成解耦,并充当能量稳态和抗氧化剂的调节剂。先前的数据表明,神经元UCP(UCP2,UCP4和UCP5)可以直接影响突触可塑性,神经传递和神经退行性过程,并且在中枢神经系统的功能和保护中起着至关重要的作用。实际上,已经观察到在阿尔茨海默氏病(AD)患者中神经元UCP的表达显着降低。在这里,我们分析了相对于健康对照(n = 442)在晚发性AD(LOAD)的散发和家族病例(n = 465)中UCP2,-3,-4和5基因的变异性。我们显示,人类UCP4的遗传变异体rs9472817,不仅显着影响个体对LOAD的敏感性,而且还调节了APOE-ε4对AD风险的影响。实际上,相对于对照组,两组患者中rs9472817-C等位基因的发生率均显着更高(家族性患者p = 6.934 * 10(-4),散发性病例p = 1.033 * 10(-3))。另外,基因-基因相互作用分析表明,纯合子CC受试者中APOE-ε4等位基因对LOAD风险的影响增加了一倍;相反,在有两个G等位基因拷贝的受试者中,取消了APOE-ε4等位基因赋予的风险。我们的发现进一步证明线粒体能量代谢效率和氧化应激是AD发病机理中的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号